Correlia Biosystems

Developer of immunoassay platforms to quantify proteins for proteomics and pharmaceutical applications

placeBerkeley, California, United States calendar_todayFounded 2013 groups21 employees language correliabio.com

Innovation

3 patent families — focus: Physics & computing; filing pace slowing. Cited 22 times.

YearFilings
20211
20232
20241
20251

Investor mix

14 investors on record; lead investors include Neotribe.

Investor typeCountShare
Venture capital1071%
Accelerator & incubator214%
Other / undisclosed214%
Coming soon